0BO vs CJH: Side-by-Side Comparison
Compare Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) and CanSino Biologics Inc (CJH) side by side: market cap EUR 38.83B vs EUR 563.26M, P/E 36.6 vs 228.0. Financials, growth and model signals on Bullrun.
| Metric | 0BO | CJH |
|---|---|---|
| Company | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | CanSino Biologics Inc |
| Country / Exchange | China · F | China · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 38.83B | EUR 563.26M |
| P/E ratio | 36.6 | 228.0 |
| Dividend yield | 0.43% | — |
| Valuation model | 24.2% overvalued | — |
| Revenue (latest FY) | — | EUR 1.06B |
| Revenue growth YoY | — | +28.4% |
| Net income | — | EUR 27.87M |
| Gross margin | — | 75.4% |
| Diluted EPS | — | 0.11 |